A carregar...
Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine
BACKGROUND: Plasmodium vivax infections are an important contributor to the malaria burden worldwide. The World Health Organization recommends a 14‐day course of primaquine (0.25 mg/kg/day, giving an adult dose of 15 mg/day) to eradicate the liver stage of the parasite and prevent relapse of the dis...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6532739/ https://ncbi.nlm.nih.gov/pubmed/24163057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004389.pub3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|